MIMO BIOSCIENCES logo
MIMO BIOSCIENCES logo
CONTACT US

EXCELENCE

And experienced + complementary team

A multidisciplinary team of leading scientists and researchers, committed to excellence and innovation in hematology-oncology.

MEET THE TEAM

Ricardo Pérez

(MBA) CEO

Jose A. Martínez-Climent

(MD y PHD) CSO & FOUNDER

Marta Larrayoz

(PHD) R&D Director

Roberto Cascante

(MSC) EXECUTIVE MBA

María José García

(PHD) LAB MANAGER

Carmen Vicente

(PHD) PDX/CDX PROJECT MANAGER

Ion Celay

(PHD) LYMPHOMA PROJECT MANAGER

Maddalen Jiménez

(PHD) MIELOMA PROJECT MANAGER

Miriam Recalde

(PHD) LYMPHOMA PROJECT MANAGER

Elena Arriazu

(PHD) MIELOMA PROJECT MANAGER

Sonia Sanz

(MSC) MIELOMA JUNIOR PROJECT MANAGER

Irati Alsua

LABORATORY TECHNICIAN

Ignacio Segovia

ANIMAL FACILITY DIRECTOR

Have a project?

GET IN TOUCH

CONTACT US
MIMO BIOSCIENCES logo

MIMO Biosciences is based in the University of Navarra campus in Pamplona (Spain).

MENU

CONTACT US

contact@mimobiosciences.com
948 194 700
Ricardo Pérez Merino. Chief Scientific Officer Founder of Mimo Bioscience

Ricardo Pérez

MBA, CEO

Economist with +25 years of experience, mainly in the PE industry having participated in more than 20 deals and directly involved in more tan 15 board of directors, most of them related to biotech industry

Jose A. Martínez-Climent. Chief Scientific Officer Founder of Mimo Bioscience

Jose A. Martínez-Climent

MD y PHD, CSO & Founder
30+ years of research in basic and translational oncology. Authors of >100 scientific articles in top hematology and oncology journals (Nature Medicine, Cancer Discovery, Cancer Cell, PNAS, Blood)
Marta Larrayoz. R&D Director of Mimo Bioscience

Marta Larrayoz

PhD, R&D Director

Marta Larráyoz, PhD, has 3 years of postdoctoral experience in Hematological Oncology (2013-2016) and 10 years developing in vivo models for solid and hematological cancers. As R&D Director at MIMO Biosciences (2024), she focuses on humanized translational platforms. Author of 20+ publications.

Roberto Cascante. MSc, Executive MBAr of Mimo Bioscience

Roberto Cascante

MSc, Executive MBA
Economist with a Master in Finance and MBA with more than 25 years of experience, having led international companies in different sectors.
María José García. Lab Manager of Mimo Bioscience

María José García

PhD, Lab Manager
Associate Professor & Cancer Research Scientist with 20+ years’ experience. Recipient of a prestigious Fulbright Postdoctoral Fellowship (2006) at Lombardi (Georgetown) and Kimmel (Jefferson) Cancer Centers. Expertise: 15+ years developing transgenic preclinical models and 15+ scientific publications.
Carmen Vicente. Myeloma Program Director of Mimo Bioscience

Carmen Vicente

PhD, PDX/CDX PROJECT MANAGER
Cancer Researcher with 10+ years’ expertise in hematologic malignancies. Completed 5-year postdoc at VIB-KU Leuven (Jan Cools Lab, Belgium). Specialized in identifying cancer-driven mutations/targeted therapies across blood cancers. Pioneered translational multiple myeloma research. Co-authored 28 publications and contributed to internationally funded projects.
Ion Celay. Lymphoma Program Director of Mimo Bioscience

Ion Celay

PhD, Lymphoma PROJECT MANAGER
Hemato-Oncology Researcher at Cima Universidad de Navarra. 10+ years’ expertise in molecular biology and lymphoma preclinical trials. Co-author of 15+ publications, inventor on an international patent, and contributor to 7 national/4 international projects. Awarded competitive fellowships: Predoctoral Grant (Navarra Gov.) and Juan de la Cierva Postdoc.
Maddalen Jiménez. Project manager of Mimo Bioscience

Maddalen Jiménez

PhD, Mieloma Project manager
Preclinical Studies Coordinator at CIMA/MIMO since 2015. Manages transgenic/syngeneic models and supervises experimental cohorts. Expertise: preclinical experimentation and molecular biology. Holds a Master’s in Immunologic Research (Complutense University of Madrid) and specialized training in Oncology/Immunology (CNB, Madrid).
Miriam Recalde. Project Manager of Mimo Bioscience

Miriam Recalde

PhD, Lymphona Project Manager
Oncology Researcher at Cima Universidad de Navarra since 2018, with a Master’s in Biochemistry, Molecular Biology and Biomedicine (Complutense University of Madrid) and specialized training in Metabolism and Cell Signaling (IIBM). Brings ~10 years of expertise in cellular/molecular biology. Co-author of 9 scientific publications. Active in lymphoma translational research and competitive national/international projects.
Elena Arriazu. Project manager of Mimo Bioscience

Elena Arriazu

PhD, MIELOMA Project manager
Research Scientist with 10+ years of expertise in molecular/cellular biology, specializing in liver fibrosis and hematologic malignancies. Completed a competitive 4-year postdoctoral fellowship at Mount Sinai’s Icahn School of Medicine (NYC), leading high-impact translational projects. Pioneered big data integration and single-cell analysis in preclinical multiple myeloma models. Co-author of 18 peer-reviewed publications and contributor to internationally funded initiatives.
Sonia Sanz. Junior Project Manager of Mimo Bioscience

Sonia Sanz

MSc, Mieloma Junior Project Manager
Biochemist with a Master’s Degree in Clinical Analysis with 5+ years of experience in preclinical oncology and immunology research. Responsible for in vivo studies with syngeneic and transgenic models at MIMO, with expertise in molecular biology and experimental design.
Irati Alsua. Laboratory Technician of Mimo Bioscience

Irati Alsua

Laboratory Technician
Graduated from ESTNA with a higher degree in Clinical and Biomedical Laboratory. Gained practical experience in genotyping and sample processing at the Dr. Climent’s laboratory. Currently a laboratory technician at MIMO Biosciences, focusing on genotyping
Ignacio Segovia. Animal Facility Director of Mimo Bioscience

Ignacio Segovia

Animal Facility Director
Since 1997, I have worked in animal research, holding various professional roles, from caretaker to head of animal facility, including veterinarian and animal welfare advisor. I have experience with multiple species and different types of facilities, including SPF, conventional, and biosecurity.